Bioequivalence study in healthy subjects

This Phase 1 trial checks whether a new coated tablet containing brivaracetam delivers the same amount of the drug into the bloodstream as the reference product Briviact. Researchers give a single dose of each version to 28 healthy adults under fasting conditions and compare key …

This completed study tested whether a new tablet containing empagliflozin and metformin works the same in the body as the reference drug Synjardy. Forty-two healthy adults took a single dose of each version under fed conditions. The goal was to check bioequivalence, meaning the t…

This study checked whether a generic version of the diabetes drug empagliflozin/metformin is absorbed into the body the same way as the brand-name drug Synjardy. 42 healthy adults took a single dose of each tablet under fed conditions. The goal was to see if the two versions are …

This study checked whether a generic version of a diabetes medication (Empagliflozin/Metformin) works the same as the brand-name version in healthy adults. 42 participants took a single dose of each pill under fed conditions, and researchers measured drug levels in the blood. The…

This study checked if a generic version of a diabetes combination pill (empagliflozin/metformin) works the same as the brand-name version in the body. 42 healthy adults took a single dose of each pill under fed conditions. The goal was to see if the two pills are bioequivalent, m…

This study checked whether a new generic rivastigmine patch works as well as the brand-name Exelon® patch. Sixty-eight healthy adults wore each patch to compare how much medicine got into their blood and how well the patch stuck to the skin. The goal was to see if the generic ver…

This study looked at how a new tablet combining two heart failure medicines (torsemide and spironolactone) works in the body compared to taking each drug separately. Twenty-four healthy adults aged 18 to 45 took single doses of the combination or the individual drugs. The goal wa…